OncoSec Medical Inc (ONCSQ)

[erostratus]

Absolutely. Management has given hints of great developments and we expect Merkel Cell Data First quarter next year. They've said, throughout correspondence with us, that they they like to present results at healthcare conferences and there are a couple of those booked for January/Feb.
They would not be seeking to present at renowned gatherings if they didnt have good things to say.
The Merkel Cell data will be especially significant since its orphan drug indication makes it highly lucrative and basically a shoo-in with the FDA on even the most minor benefit.
We're currently greatly undervalued-fair value range being at the dollar level.

There might be a minor pullback to lower 40s these days, there might not be.
Either way, I'm accumulating on all dips, and expecting significant price appreciation near-term.
GTLY